Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2012

Open Access 01-12-2012 | Study protocol

The efficacy of a brief intervention to reduce alcohol misuse in patients with HIV in South Africa: study protocol for a randomized controlled trial

Authors: Diana Huis in ’t Veld, Linda Skaal, Karl Peltzer, Robert Colebunders, John V Ndimande, Supa Pengpid

Published in: Trials | Issue 1/2012

Login to get access

Abstract

Background

Alcohol abuse comes with risks for increased morbidity and mortality among patients with HIV. This study aims to determine the prevalence of alcohol use and other risk factors in a sample of primary care patients with HIV in South Africa and to assess a brief intervention to reduce the use of alcohol in this group.

Methods/Design

A single-blinded randomized controlled trial is designed to determine the efficacy of a brief intervention to reduce hazardous alcohol use in patients with HIV. The study will be carried out on out-patients with HIV in two primary healthcare HIV clinics near Pretoria, South Africa. Alcohol use will be assessed with the Alcohol Use Disorder Identification Test questionnaire. Other data that will be collected relate to health-related quality of life, depression, sexual behavior, internalized AIDS stigma, HIV-related information and adherence to antiretroviral therapy (self-reported 7-day recall of missed doses, Visual Analog Scale and pill count). The intervention consists of a brief counseling session to reduce alcohol risk; the control group receives a health education leaflet.

Discussion

The findings will be important in the public health setting. If the intervention proves to be efficient, it could potentially be incorporated into the HIV care policy of the Ministry of Health.

Trial registration

Pan African Clinical trial Registry: PACTR201202000355384
Literature
1.
2.
3.
4.
Reid MC, Fiellin DA, O’Connor PG: Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999, 159: 1681-10.1001/archinte.159.15.1681.CrossRefPubMed
5.
Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, Katabira E, Nachega JB: Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav. 2011, [Epub ahead of print]
6.
Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S: Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS. 2008, 22: 147-158. 10.1089/apc.2007.0102.CrossRefPubMed
7.
Bassett MT, McFarland WC, Ray S, Mbizvo MT, Machekano R, Van de Wijgert JHHM, Katzenstein DA: Risk factors for HIV infection at enrollment in an urban male factory cohort in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 13: 287-293. 10.1097/00042560-199611010-00012.CrossRefPubMed
8.
Ayisi JG, Van Eijk AM, Ter Kuile FO, Kolczak MS, Otieno JA, Misore AO, Kager PA, Steketee RW, Nahlen BL: Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. Int J STD AIDS. 2000, 11: 393-401. 10.1258/0956462001916119.CrossRefPubMed
9.
Fritz KE, Woelk GB, Bassett MT, McFarland WC, Routh JA, Tobaiwa O, Stall RD: The association between alcohol use, sexual risk behavior and HIV infection among men attending beerhalls in Harare, Zimbabwe. AIDS Behav. 2002, 6: 221-228. 10.1023/A:1019887707474.CrossRef
10.
Hargreaves JR, Morison LA, Chege J, Rutenburg N, Kahindo M, Weiss HA, Hayes R, Buve A, Study Group on Heterogeneity of HIV Epidemics in African Cities: Socioeconomic status and risk of HIV infection in an urban population in Kenya. Trop Med Int Health. 2002, 7: 793-802. 10.1046/j.1365-3156.2002.00943.x.CrossRefPubMed
11.
Fisher JC, Bang H, Kapiga SH: The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis. 2007, 34: 856-863. 10.1097/OLQ.0b013e318067b4fd.CrossRefPubMed
12.
Fisher JC, Cook PA, Kapiga SH: Alcohol use before sex and HIV risk: situational characteristics of protected and unprotected encounters among high-risk African women. Sex Transm Dis. 2010, 37: 571-578. 10.1097/OLQ.0b013e3181dbafad.CrossRefPubMed
13.
Woolf-King S, Maisto SA: Alcohol use and high-risk sexual behavior in sub-Saharan Africa: a narrative review. Arch Sex Behav. 2011, 40: 17-42. 10.1007/s10508-009-9516-4.CrossRefPubMed
14.
Peltzer K, Mlambo G, Phaweni K: Factors determining prenatal HIV testing for prevention of mother to child transmission of HIV in Mpumalanga, South Africa. AIDS Behav. 2010, 14: 1115-1123. 10.1007/s10461-009-9662-7.CrossRefPubMed
15.
Msuya SE, Mbizvo E, Uriyo J, Stray-Pedersen B, Sam NE, Hussain A: Predictors of failure to return for HIV test results among pregnant women in Moshi Tanzania. J Acquir Immune Defic Syndr. 2006, 43: 85-90. 10.1097/01.qai.0000225016.50890.7e.CrossRefPubMed
16.
Abaynew Y, Deribew A, Deribe K: Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case–control study. AIDS Res Ther. 2011, 8: 8-10.1186/1742-6405-8-8.CrossRefPubMedPubMedCentral
17.
Kip E, Ehlers VJ, Van der Wal DM: Patients’ adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009, 41: 149-157. 10.1111/j.1547-5069.2009.01266.x.CrossRefPubMed
18.
Venkatesh KK, Srikrishnan AK, Mayer KH, Kumarasamy N, Raminani S, Thamburaj E, Prasad L, Triche EW, Solomon S, Safren SA: Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS. 2010, 24: 795-803. 10.1089/apc.2010.0153.CrossRefPubMedPubMedCentral
19.
Jaquet A, Ekouevi DK, Bashi J, Aboubakrine M, Messou E, Malga M, Traore HA, Zannou MD, Guehi C, Ba-Gomis FO, Minga A, Allou G, Eholie SP, Bissagnene E, Sasco AJ, Dabis F: Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West-Africa. Addiction. 2010, 105: 1416-1421. 10.1111/j.1360-0443.2010.02978.x.CrossRefPubMed
20.
Van Geertruyden JP, Woelk G, Mukumbi H, Ryder R, Colebunders R: Alcohol and antiretroviral adherence? What about Africa?. J AIDS. 2010, 54: e10-
21.
Etienne M, Hossain M, Redfield R, Stafford K, Amoroso A: Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc Physicians AIDS Care. 2010, 9: 98-103. 10.1177/1545109710361383.CrossRef
22.
Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A: Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010, 26: 511-518. 10.1089/aid.2009.0211.CrossRefPubMedPubMedCentral
23.
Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R: Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007, 46: 194-199. 10.1097/QAI.0b013e318142aabb.CrossRefPubMedPubMedCentral
24.
Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC, Veterans Aging Cohort 3-Site Study: How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk?. J AIDS. 2003, 33: 521-525.
25.
Bertholet N, Daeppen JB, Wietlisback V, Fleming M, Burnand B: Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med. 2005, 165: 986-995. 10.1001/archinte.165.9.986.CrossRefPubMed
26.
Parsons JT, Golub SA, Rosof E, Holder C: Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007, 46: 443-450. 10.1097/QAI.0b013e318158a461.CrossRefPubMedPubMedCentral
27.
Samet JH, Horton NJ, Meli S, Dukes K, Tripp T, Sullivan L, Freedberg KA: A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antiviral Ther. 2005, 10: 83-93.
28.
Papas RK, Sidle JE, Martino S, Baliddawa JB, Songole R, Omolo OE, Gakinya BN, Mwaniki MM, Adina JO, Nafula T, Owino-Ong’or WD, Bryant KJ, Carroll KM, Goulet JL, Justice AC, Maisto SA: Systematic cultural adaptation of congnitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in Western Kenya. AIDS Behav. 2010, 14: 669-678. 10.1007/s10461-009-9647-6.CrossRefPubMedPubMedCentral
29.
30.
Kaner E, Bland M, Cassidy P, Coulton S, Deluca P, Drummond C, Gilvarry E, Godfrey C, Heather N, Myles J, Newbury-Birch D, Oyefeso A, Parrott S, Perryman K, Phillips T, Shenker D, Shepherd J: Screening and brief interventions for hazardous and harmful alcohol use in primary care: a cluster randomised controlled trial protocol. BMC Publ Health. 2009, 9: 287-10.1186/1471-2458-9-287.CrossRef
31.
Kaner EF, Dickinson HO, Beyer FR, Campbell F, Schlesinger C, Heather N, Saunders JB, Burnand B, Pienaar ED: Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007, 2: CD004148-PubMed
32.
O’Connell K, Saxena S, Skevington SM, WHOQOLHIV Group: WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: results from a field test. AIDS Care. 2004, 16: 882-889. 10.1080/09540120412331290194.CrossRef
33.
34.
Andresen EM, Malmgren JA, Carter WB, Patrick DL: Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994, 10: 77-84.PubMed
35.
Kilbourne AM, Justice AC, Rollman BL, McGinnis KA, Rabeneck L, Weissman S, Smola S, Schultz R, Whittle J, Rodriquez-Barradas M: Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med. 2002, 17: 512-520. 10.1046/j.1525-1497.2002.10803.x.CrossRefPubMedPubMedCentral
36.
Mulrow CD, Williams JW, Gerety MB, Ramirez G, Montiel OM, Gerber C: Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995, 122: 913-921.CrossRefPubMed
37.
Kalichman SC, Simbayi LC, Cloete A, Mthembuc PP, Mkhontac RN, Ginindza T: Measuring AIDS stigmas in people living with HIV/AIDS: the internalized AIDS related Stigma Scale. AIDS Care. 2009, 21: 87-93. 10.1080/09540120802032627.CrossRefPubMed
38.
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: AUDIT. The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care. 2nd edition. WHO/MSD/MSB/01.6a. Geneva: World Health Organization, Department of Mental Health and Substance Dependence
39.
Mannheimer S, Thackeray L, Huppler Hullsiek K, Chesney M, Gardner EM, Wu AW, Telzak EE, Lawrence J, Baxter J, Friedland G, Terry Beirn Community Program for Clinical Research on AIDS: A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care. 2008, 20: 161-169. 10.1080/09540120701534699.CrossRefPubMed
40.
Maneesriwongul WL, Tulathong S, Fennie KP, Williams AB: Adherence to antiretroviral medication among HIV-positive paitents in Thailand. J Acquir Immune Defic Syndr. 2006, 43 (Suppl. 1): S119-S122.CrossRefPubMed
41.
Sarna A, Luchters S, Geibel S, Munyao P, Kaai S, Khadija S, Kishor M, Hawken M, Van Dam J, Temmerman M: Promoting Adherence through a Directly Administered Antiretroviral Therapy (DAART) Strategy in Mombasa, Kenya. Horizons Research Update. 2005, Nairobi: Population Council
42.
Babor TF, Higgins-Biddle JC: Brief Intervention for Hazardous and Harmful Drinking: A Manual for Use in Primary Care Settings. WHO/MSD/MSB/01.6b. 2001, Geneva: World Health Organization, Department of Mental Health and Substance Dependence
43.
44.
Metadata
Title
The efficacy of a brief intervention to reduce alcohol misuse in patients with HIV in South Africa: study protocol for a randomized controlled trial
Authors
Diana Huis in ’t Veld
Linda Skaal
Karl Peltzer
Robert Colebunders
John V Ndimande
Supa Pengpid
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Trials / Issue 1/2012
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-13-190

Other articles of this Issue 1/2012

Trials 1/2012 Go to the issue

Methodology

Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach

Research

Developing a guideline for clinical trial protocol content: Delphi consensus survey

Methodology

Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people

Study protocol

Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trial

Study protocol

Psychosocial group intervention to enhance self-management skills of people with dementia and their caregivers: study protocol for a randomized controlled trial

Study protocol

Self-help materials for the prevention of smoking relapse: study protocol for a randomized controlled trial